Literature DB >> 24028088

Sustained improvement of gas exchange and lung mechanics by vaporized perfluorocarbon inhalation in piglet acute lung injury model.

Xiaoguang Wang1, Jianpeng Zhang, Xiaoling Li, Youning Liu, Haibo Yang, Xiaowei Zhao, Lixin Xie, Lihua Yin.   

Abstract

INTRODUCTION: New methods for perfluorocarbon (PFC) application have been proposed which include aerosolization and vaporization. However, the experimental documentation of efficacy of vaporization of PFC in the treatment of acute respiratory distress syndrome (ARDS) is still lacking.
OBJECTIVES: This study aims to examine the effects of vaporized PFC on gas exchange and lung mechanics in a piglet model with ARDS.
METHODS: Lung injury was induced in 16 piglets by infusing detergent through tracheal intubation. Eight piglets were treated with vaporized PFC for 2 h followed by 6 h of volume-controlled ventilation. Another eight piglets receiving 8 h volume-controlled ventilation were used as controls. Blood gases, lung mechanical and hemodynamic parameters were measured.
RESULTS: Vaporized PFC treatment significantly increased oxygenation index (P/F ratio) and static lung compliance (Cst) 2 h after therapy compared with the control group (P<0.05). The P/F ratio reached a peak 5.5 h after the therapy and remained at an increased level for at least 6 h compared with the control group (P<0.001). Additionally, 6 h post treatment, peak inspiratory pressure was significantly reduced in PFC group when compared with the control group (P<0.05), and Cst was significantly higher in the PFC group than in the control group (P=0.001).
CONCLUSIONS: Inhalation of vaporized PFC results in sustained improvement of pulmonary gas exchange and lung mechanics in a detergent-induced animal model of lung injury. Therefore, the non-invasive vaporization application technique would be a reasonable alternative to administer perfluorocarbons in severe lung injury.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute respiratory distress syndrome; fluorochemicals; inhalation; vaporization

Mesh:

Substances:

Year:  2013        PMID: 24028088     DOI: 10.1111/crj.12053

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

1.  Perfluorocarbon Protects against Lipopolysaccharide-Induced Apoptosis of Endothelial Cells in Pulmonary Microvessels.

Authors:  Y Xu; T Wu; P Wang; Z X Liang; S S Shi; S F Xu; X J Liu; Q Tian
Journal:  Bull Exp Biol Med       Date:  2021-03-16       Impact factor: 0.804

Review 2.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.

Authors:  Makhloufi Zoulikha; Qingqing Xiao; George Frimpong Boafo; Marwa A Sallam; Zhongjian Chen; Wei He
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 11.413

3.  Therapeutic effect of intravenous infusion of perfluorocarbon emulsion on LPS-induced acute lung injury in rats.

Authors:  Shike Hou; Hui Ding; Qi Lv; Xiaofeng Yin; Jianqi Song; Ning Xu Landén; Haojun Fan
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 4.  Preclinical and clinical studies of smoke-inhalation-induced acute lung injury: update on both pathogenesis and innovative therapy.

Authors:  Bingxin Guo; Yichun Bai; Yana Ma; Cong Liu; Song Wang; Runzhen Zhao; Jiaxing Dong; Hong-Long Ji
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

5.  Effect of vaporized perfluorocarbon on oxidative stress during the cold ischemia phase of lung graft preservation.

Authors:  Renata Salatti Ferrari; Leonardo Dalla Giacomassa Rocha Thomaz; Lucas Elias Lise Simoneti; Jane Maria Ulbrich; Cristiano Feijó Andrade
Journal:  J Bras Pneumol       Date:  2019-03-28       Impact factor: 2.624

Review 6.  Emerging therapies for smoke inhalation injury: a review.

Authors:  Alexandra Mercel; Nick D Tsihlis; Rob Maile; Melina R Kibbe
Journal:  J Transl Med       Date:  2020-03-30       Impact factor: 5.531

7.  Partial liquid ventilation-induced mild hypothermia improves the lung function and alleviates the inflammatory response during acute respiratory distress syndrome in canines.

Authors:  Fusheng Wei; Shuang Wen; Han Wu; Longxian Ma; Yuanlu Huang; Lei Yang
Journal:  Biomed Pharmacother       Date:  2019-08-14       Impact factor: 7.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.